SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending, with community members highlighting its potential involvement in the "Golden Dome" defense project and recent strong earnings. Some see a breakout opportunity if it can push through range highs on volume, while others discuss the company's technology and growth potential in the aerospace and defense sector. There is also discussion around possible short attacks.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending downwards as investors react to concerns about AI revenue specifics and lower margin expectations despite strong earnings and a substantial AI product backlog, leading to a significant stock decline. The community is debating whether this drop is an overreaction or a correction, with some seeing a buying opportunity while others anticipate further declines. Some traders point towards analysts' upgrades and strong fundamentals as reasons for an imminent rebound.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards as the community discusses recent price drops and potential support levels, with some speculating about market manipulation and tax-loss harvesting. Concerns about an AI bubble and the company's debt are circulating, while others maintain a long-term bullish outlook based on IREN's Microsoft deal and growth potential in the data center space. Community members are debating the impact of Bitcoin's performance and potential news catalysts on IREN's future price movement.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to a significant surge in price and volume, sparking discussions about a potential short squeeze. The community is actively debating its overnight trading activity and potential for further gains, drawing comparisons to other high-flying stocks. Some traders are pointing to the company's focus on AI-powered robotics as a reason for optimism, while others are wary of a potential pump and dump.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its RAD 101 Phase 2b imaging trial, showing promising results in brain metastases patients. The community is discussing the potential for a short squeeze and speculating on price targets, with some highlighting the company's cash runway through 2026. High trading volume and aggressive volatility, paired with a webinar scheduled, are contributing to the heightened interest.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound's price action is sparking debate, with some traders calling out potential pump-and-dump schemes while others see an opportunity amidst market volatility. Community members are weighing the impact of treasury levels, governance, and competition from other DeFi protocols like AAVE. Discussions also touch on potential real-world asset (RWA) tokenization and the Compound Foundation's activities.

Didi Global, Inc. engages in the operation of mobility platforms that provides ride hailing and other related services. It operates through the following segments: China Mobility, International, and Other Initiative. The China Mobility segment consists of ride hailing, taxi hailing, chauffeur and hitch services. The International segment includes ride hailing and food delivery services in international markets, outside of China. The Other Initiatives segment mainly consists of bike and e-bike sharing, certain auto solutions, intra-city freight, community group buying, autonomous driving, and financial services. The company was founded by Wei Cheng, Qing Liu, Bo Zhang and Rui Wu on January 11, 2013 and is headquartered Beijing, China.

DiDi Global Inc - ADR

DiDi Global (DIDIY) is trending due to speculation around its potential Hong Kong relisting, fueled by positive movement in Chinese markets and analyst upgrades. The community discusses the likelihood of the relisting, potential timelines, and the impact of share buybacks and the recent class action settlement. Some investors express frustration with the stock's volatility while remaining optimistic about its long-term potential, especially in the robotaxi market.

Numeraire

Numeraire is trending amid discussions of its low circulating supply and potential for significant price movement, with some community members eyeing previous all-time highs. Talk centers on its unique position as an AI-driven crypto hedge fund and speculation that major players are accumulating the token. Recent performance and the possibility of increased AUM are also fueling bullish sentiment.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending amid mixed sentiment, with some traders expressing frustration over its price action and comparing it unfavorably to Bitcoin and other altcoins. Community discussions revolve around whether the project is a viable long-term investment or a failing endeavor, while others point to developments and partnerships in Japan as potential catalysts. Technical analysis and predictions for potential pumps and dumps are also circulating.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

KYTX is experiencing increased attention due to analyst upgrades and positive phase 2 trial results for its CAR-T therapy in stiff person syndrome, with plans for FDA submission in 2026. Despite a recent equity offering causing a temporary dip, the community sees long-term potential, particularly in the broader application of CAR-T for autoimmune diseases. Community members are actively discussing potential price targets and the possibility of an acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quanterix (QTRX) Projected to Post Earnings on Monday

Quanterix (NASDAQ:QTRX) will be releasing earnings before the market opens on Monday, December 22. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-12-22-quanterix-co-stock...

Quanterix (NASDAQ:QTRX) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised Quanterix from a "sell" rating to a "hold" rating in a report on Saturday...

Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of "Hold" by Analysts

Quanterix Corporation (NASDAQ:QTRX - Get Free Report) has earned an average rating of "Hold" from the five ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research...

Russell Investments Group Ltd. Has $2.82 Million Stock Holdings in Quanterix Corporation $QTRX

Russell Investments Group Ltd. lowered its holdings in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 30.0% in the second quarter, according to its most recent 13F filing with the...

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of...

Quanterix Corporation $QTRX Stock Holdings Decreased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lessened its position in Quanterix Corporation (NASDAQ:QTRX - Free Report) by 53.7% in the 2nd quarter, according to the company in its most recent filing with the...

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the publication of a landmark study in...

Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results, Misses Estimates By $0.13 EPS

Quanterix (NASDAQ:QTRX - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.13...

Quanterix Corp Q3 Loss Increases, Misses Estimates

(RTTNews) - Quanterix Corp (QTRX) revealed Loss for its third quarter that increased from last year and missed the Street estimates...

Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates

Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Current Price	$7.41
Prev Close	$7.56
Open	$7.63
Dividend Yield	0.00%
50-Day Moving Average	$6.14
Beta	1.68
Avg. Volume	780,301.21
PE Ratio	-3.18

52-Week High	$12.41
52-Week Low	$4.05
Market Capitalization	$353.13M
EPS (Annual)	-$1.00
Price to Book	1.10
Revenue Per Employee	$291,764.33
Enterprise Value/EBITDA	N/A

QTRX
Quanterix Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest QTRX News

QTRXQuanterix Corp